Malcolm Lloyd-Smith

Companies

• Neurocrine BiosciencesChief Regulatory Officer Oct 1, 2014 to Feb 8, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Neurocrine Biosciences NBIX42,337 shares²$5.8M at $136.95Feb 8, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 8, 2023Sold 701 shares at $103.83 of Neurocrine Biosciences²
• Feb 7, 2023Sold 12,801 shares at $102.41 of Neurocrine Biosciences²
• Feb 7, 2023Sold 1,015 shares at $102.16 of Neurocrine Biosciences²
• Feb 6, 2023Sold 801 shares at $105.82 of Neurocrine Biosciences²
• Jan 31, 2023Sold 1,666 shares at $110.02 of Neurocrine Biosciences³
• Aug 15, 2022Exercised options 1,227 shares at $81.49 of Neurocrine Biosciences⁴
• Aug 15, 2022Exercised options 3,361 shares at $43.24 of Neurocrine Biosciences⁴
• Aug 15, 2022Exercised options 3,455 shares at $35.99 of Neurocrine Biosciences⁴
• Aug 12, 2022Sold 21,533 shares at $105.95 of Neurocrine Biosciences⁴
• Aug 12, 2022Exercised options 21,533 shares at $35.99 of Neurocrine Biosciences⁴
• Feb 8, 2022Sold 701 shares at $79.53 of Neurocrine Biosciences⁵
• Feb 7, 2022Sold 801 shares at $80.65 of Neurocrine Biosciences⁵
• Feb 7, 2022Sold 1,015 shares at $80.73 of Neurocrine Biosciences⁵
• Feb 7, 2022Sold 865 shares at $80.78 of Neurocrine Biosciences⁵